Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Innoviva, Inc. | Officer | Common Stock | 40.5K | $653K | $16.13 | May 20, 2024 | Direct |
Innoviva, Inc. | Officer | Non-statutory Stock Option | 120K | Mar 5, 2024 | Direct | ||
Innoviva, Inc. | Officer | Nonqualified Stock Option | 93.1K | Jan 18, 2024 | Direct | ||
Entasis Therapeutics Holdings Inc. | Chief of Pharma Sciences & MFG | Common Stock | 0 | $2.20 | Jul 11, 2022 | Direct | |
Entasis Therapeutics Holdings Inc. | Chief of Pharma Sciences & MFG | Stock Option (right to buy) | 0 | Jul 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INVA | Innoviva, Inc. | May 20, 2024 | 1 | -$4.32K | 4 | May 21, 2024 | Officer |
INVA | Innoviva, Inc. | Mar 5, 2024 | 2 | $190K | 4 | Mar 7, 2024 | Officer |
INVA | Innoviva, Inc. | Feb 20, 2024 | 1 | -$12.8K | 4 | Feb 22, 2024 | Officer |
INVA | Innoviva, Inc. | Jan 18, 2024 | 2 | -$25.7K | 4 | Jan 22, 2024 | Officer |
INVA | Innoviva, Inc. | Jan 1, 2024 | 0 | $0 | 3 | Jan 10, 2024 | Officer |
ETTX | Entasis Therapeutics Holdings Inc. | Jul 7, 2022 | 6 | -$38.7K | 4 | Jul 11, 2022 | Chief of Pharma Sciences & MFG |
ETTX | Entasis Therapeutics Holdings Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 19, 2022 | Chief of Pharmaceutical Sciences and Manufacturing |
ETTX | Entasis Therapeutics Holdings Inc. | Nov 2, 2021 | 1 | -$10.8K | 4 | Nov 3, 2021 | Chief, Pharma Sciences & MFG. |
ETTX | Entasis Therapeutics Holdings Inc. | Oct 19, 2021 | 2 | -$12K | 4 | Oct 20, 2021 | Chief of Pharmaceutical Sciences and Manufacturing |
ETTX | Entasis Therapeutics Holdings Inc. | Jul 16, 2021 | 2 | $0 | 4 | Feb 15, 2022 | Chief of Pharmaceutical Sciences and Manufacturing |